Why is Chongqing Zhifei Biological Products Co., Ltd. ?
- The company has declared negative results for the last 6 consecutive quarters
- NET SALES(Q) At CNY 2,362.25 MM has Fallen at -63.57%
- NET PROFIT(Q) At CNY -303.21 MM has Fallen at -160.09%
- OPERATING CASH FLOW(Y) Lowest at CNY 163.84 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -29.77%, its profits have fallen by -113.5%
- At the current price, the company has a high dividend yield of 1.6
- Along with generating -29.77% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Chongqing Zhifei Biological Products Co., Ltd. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Fallen by -25.93% (YoY
At CNY 2,362.25 MM has Fallen at -63.57%
At CNY -303.21 MM has Fallen at -160.09%
Lowest at CNY 163.84 MM
Lowest at 0.81%
At CNY 70.05 MM has Grown at 10.93%
Lowest at CNY -283.9 MM
Lowest at -12.02 %
Lowest at CNY -331.19 MM
Highest at 39.45 %
Lowest at 0.71%
Lowest at 0.76%
Lowest at CNY -0.13
Here's what is working for Chongqing Zhifei Biological Products Co., Ltd.
Raw Material Cost as a percentage of Sales
Here's what is not working for Chongqing Zhifei Biological Products Co., Ltd.
Net Sales (CNY MM)
Pre-Tax Profit (CNY MM)
Net Profit (CNY MM)
Net Sales (CNY MM)
Interest Paid (CNY MM)
Operating Profit (CNY MM)
Operating Profit to Sales
Pre-Tax Profit (CNY MM)
Net Profit (CNY MM)
Operating Cash Flows (CNY MM)
Interest Paid (CNY MM)
EPS (CNY)
Debt-Equity Ratio
Inventory Turnover Ratio
Debtors Turnover Ratio






